Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Share News (GWP)

  • There is currently no data for GWP

GWP.L News

London open: Footsie surges after China's currency move
21 Jun 2010

London open: Footsie surges after China's currency move

News over the weekend that China will relax its currency's peg to the dollar has sparked a rush into mining stocks. It's hoped the decision will boos...

GW Pharma launches Sativex in UK
21 Jun 2010

GW Pharma launches Sativex in UK

Shares in GW Pharmaceuticals hit a 52-week high as the cannabis based medicine developer announced the UK launch of Sativex, a spray for the treatment...

UPDATE: GW Pharm To Seek Further EU Approvals For Sativex
21 Jun 2010

UPDATE: GW Pharm To Seek Further EU Approvals For Sativex

(Adds drug price.) By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--Drug company GW Pharmaceuticals PLC (GWP.LN) Monday said it...

GW Pharm To Seek Further EU Approvals For Sativex After UK OK
21 Jun 2010

GW Pharm To Seek Further EU Approvals For Sativex After UK OK

LONDON (Dow Jones)--Drug company GW Pharmaceuticals PLC (GWP.LN) Monday said it will apply to sell multiple sclerosis medicine Sativex in other Europe...

UPDATE: GW Pharmaceuticals Receives UK Sativex Approval
18 Jun 2010

UPDATE: GW Pharmaceuticals Receives UK Sativex Approval

(Adds detail and share price.) By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--U.K. drug developer GW Pharmaceuticals PLC (GWP...

GW Pharmaceuticals Receives Sativex Approval
18 Jun 2010

GW Pharmaceuticals Receives Sativex Approval

LONDON (Dow Jones)--Drug maker GW Pharmaceuticals PLC (GWP.LN) Friday said it received a license for its cannabis-derived multiple sclerosis medicine ...

C&W Communications bosses buy
11 Jun 2010

C&W Communications bosses buy

Two executive directors of Cable & Wireless Communications have taken advantage of the shares going ex-dividend on Wednesday and added to their shareh...

Confident GW on a high
20 May 2010

Confident GW on a high

Shares in cannabis based medicine developer GW Pharmaceuticals were on a high Thursday, hitting their highest level in 52 weeks after the company expr...